Shareholders' Equity (Tables)

3 Months Ended

Mar. 31, 2021

Shareholders' Equity

Summary of comprehensive income (loss)

	Three Months Ended March 31,
	2021			2020
Consolidated net income	$	57.8		$	10.6
Foreign currency translation adjustments		(19.5	)		(13.0	)
Pension liability adjustments, net of tax		3.3			14.5
Net comprehensive income		41.6			12.1
Less: Comprehensive income (loss) attributable to noncontrolling interests		0.9			(0.1	)
Less: Comprehensive income (loss) attributable to redeemable noncontrolling interest		—			(0.5	)
Comprehensive income attributable to Bruker Corporation	$	40.7		$	12.7

Summary of the components of accumulated other comprehensive income (loss), net of tax

The following is a summary of the components of accumulated other comprehensive income (loss), net of tax (dollars in millions):

	Foreign Currency Translation			Pension Liability Adjustment			Accumulated Other Comprehensive Income (Loss)
Balance at December 31, 2020	$	49.4		$	(45.7	)	$	3.7
Other comprehensive income (loss) before reclassifications		(19.1	)		2.6			(16.5	)
Realized loss on amounts reclassified from other comprehensive income (loss), net of tax		—			0.7			0.7
Net current period other comprehensive income (loss)		(19.1	)		3.3			(15.8	)
Balance at March 31, 2021	$	30.3		$	(42.4	)	$	(12.1	)

Schedule of the impact of stock-based compensation expense

The Company recorded stock-based compensation expense as follows in the unaudited condensed consolidated statements of income and comprehensive income (dollars in millions):

	Three Months Ended March 31,
	2021		2020
Costs of product revenue	$	0.5	$	0.5
Selling, general and administrative		2.4		2.0
Research and development		0.5		0.5
Total stock-based compensation	$	3.4	$	3.0